BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18652401)

  • 21. [Biomarker for chemotherapy in patients with colorectal cancer].
    Matsusaka S
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):11-4. PubMed ID: 19151559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.
    Benoist S; Nordlinger B
    Ann Surg Oncol; 2009 Sep; 16(9):2385-90. PubMed ID: 19554377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidylate synthase expression in colorectal cancer: the never-ending story.
    Vincenzi B; Santini D; Tonini G
    J Clin Oncol; 2005 Mar; 23(9):2108; author reply 2108-9. PubMed ID: 15774806
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular markers of chemotherapy in advanced colorectal cancer: back to square one.
    Sobrero A
    Eur J Cancer; 2009 Jul; 45(11):1902-3. PubMed ID: 19502051
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tailored treatment to patients with metastatic colorectal cancer].
    Pfeiffer P; Qvortrup C; Hansen TP
    Ugeskr Laeger; 2009 Mar; 171(13):1098. PubMed ID: 19321093
    [No Abstract]   [Full Text] [Related]  

  • 28. Implications of genetic testing in the management of colorectal cancer.
    Stoehlmacher J; Lenz HJ
    Am J Pharmacogenomics; 2003; 3(2):73-88. PubMed ID: 12749725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacogenetics and biomarkers in colorectal cancer.
    Strimpakos AS; Syrigos KN; Saif MW
    Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer.
    Arkenau HT; Brunetto AT; Barriuso J; Olmos D; Eaton D; de Bono J; Judson I; Kaye S
    Oncology; 2009; 76(3):151-6. PubMed ID: 19169046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current pharmacogenetics in colorectal cancer--do they have an impact on our clinical treatment strategies?
    Goekkurt E; Stoehlmacher J
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):577-8. PubMed ID: 16372523
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacogenetics in colorectal cancer: a systematic review.
    Funke S; Brenner H; Chang-Claude J
    Pharmacogenomics; 2008 Aug; 9(8):1079-99. PubMed ID: 18681783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer pharmacogenetics: polymorphisms, pathways and beyond.
    Ulrich CM; Robien K; McLeod HL
    Nat Rev Cancer; 2003 Dec; 3(12):912-20. PubMed ID: 14740638
    [No Abstract]   [Full Text] [Related]  

  • 35. The changing paradigm of colorectal cancer therapy: the impact of vascular endothelial growth factor and epidermal growth factor and epidermal growth factor receptor inhibition. Introduction.
    Chase JL
    Pharmacotherapy; 2008 Nov; 28(11 Pt 2):17S. PubMed ID: 18980547
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy for metastatic colorectal cancer].
    Iwasa S; Shimada Y
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer: pharmacogenetics support for the correct drug prescription.
    Olivera G; Sendra L; Herrero MJ; Puig C; AliƱo SF
    Pharmacogenomics; 2019 Jul; 20(10):741-763. PubMed ID: 31368847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
    Robaey P; Krajinovic M; Marcoux S; Moghrabi A
    Dev Disabil Res Rev; 2008; 14(3):211-20. PubMed ID: 18924160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine pharmacogenetics.
    Maxwell JR; Wilson AG
    Cytokine; 2006 Mar; 33(6):362-6. PubMed ID: 16529939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.